Skip to main content

Biopharmaceutical companies tackle clinical trial transparency

  • Chapter
  • 582 Accesses

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pharmaceutical Research and Manufacturing Association. Pharmaceutical companies to make more information available about clinical trials. Available at http://www.phrma.org/meiaroom/press/releases/06.01.2005.1112. cfm (Accessed 13 March 2005)

    Google Scholar 

  2. United States Food and Drug Administration. Section 113 Food and Drug Administration Modernization Act of 1997. Available at: http://lhncbc.nlm.nih.gov/clin/113.html (Accessed 8 February 2006)

    Google Scholar 

  3. Office of the New York State Attorney General Eliot Spitzer. Major pharmaceutical firm concealed information. Available at http://www.oag.state.ny.us/press/2004/jun/jun2b_04.html (Accessed 17 March 2005)

    Google Scholar 

  4. Fair Access to Clinical Trials Act of 2005. US Senate S470. Available at http://olpa.od.nih.gov/tracking/109/senate_bills/session1/s-470.asp (Accessed 21 March 2005)

    Google Scholar 

  5. Pharmaceutical Research and Manufacturing Association. International alliance of pharmaceutical associations agrees on principles for disclosing information. Available at http://www.phrma.org/mediaroom/press/releases/06.01.2005.1114.cfm (Accessed 13 March 2005)

    Google Scholar 

  6. CenterWatch (2005) Clinical trial transparency efforts multiple. The CenterWatch Monthly 12(11): 1–13

    Google Scholar 

  7. World Health Organization. WHO International Clinical Trials Registration Platform: Unique ID assignment. Geneva: WHO. Available at http://www.who.int/ictrp/commnets2/en/index.html (Accessed 23 January 2006)

    Google Scholar 

  8. Haug C, Gøtzsche PC, Schroeder TV (2005) Registries and registration of clinical trials. N Engl J Med 353: 2811–2812

    Article  PubMed  CAS  Google Scholar 

  9. McDonald D, Molnari PM (2005) Breaking the trial result disclosure logjam now. Appl Clin Trials 11: 37–38

    Google Scholar 

  10. F Hoffman-La Roche. Roche clinical trial registry and results database launched on www.roche-trials.com. Available at www.roche.com (Accessed 16 February 2006)

    Google Scholar 

  11. Metz C. Interpretation and next steps to achieve an acceptable blend of the position statement. Clinical Trial Registries and Registers Conference, Pharmaceutical Education Associates, Philadelphia, PA; September 22–23, 2005.

    Google Scholar 

  12. Maine Department of Health and Human Services. Clinical Trial Registration Law Summary. Available at http://www.maine.gov/dhhs/boh/clinical_trials.htm. (Accessed 16 February 2006)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

McDonald, D., Zisson, S. (2006). Biopharmaceutical companies tackle clinical trial transparency. In: Foote, M. (eds) Clinical Trial Registries. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7583-6_9

Download citation

Publish with us

Policies and ethics